ليست عنوان مقالات لاتين Anger expression, partner support, and quality of life in cancer patients Angular distribution of X-ray photoelectrons emitted from silver

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Anger expression, partner support, and quality of life in cancer patients

2

Anger in Adolescent Boy Athletes: a Comparison among Judo, Karate, Swimming and Non Athletes

3

Anger in chronic pain: Investigations of anger targets and intensity

4

Anger in healthy men: a PET study using script-driven imagery

5

Anger in prisoners: women are different from men

6

Anger in the Trajectory of Healing From Childhood Maltreatment

7

Anger in UK as discredited doctor is elected to doctorsʹ ruling body

8

Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids

9

Anger Management among Medical Undergraduate Students and Its Impact on Their Mental Health and Curricular Activities

10

Anger Management and Control in Social and Behavioral Sciences: A Systematic Review of Literature on Biopyschosocial Model

11

Anger Management and Factors that Influence Anger in Physicians

12

Anger Management May Save Your Life: New Insights Into Emotional Precipitants of Ventricular Arrhythmias

13

Anger management style and the prediction of treatment outcome among male and female chronic pain patients

14

Anger on ruling not to prosecute Irish doctors

15

Anger over dangerous withdrawal of antipsychotics from Pakistan

16

Anger over handling of Madagascarʹs cholera epidemic

17

Anger response styles and reaction to provocation

18

Anger rumination in Hong Kong and Great Britain: Validation of the scale and a cross-cultural comparison

19

Anger scale and anger types of patients with fifth metacarpal neck fracture

20

Anger scale and anger types of patients with fifth metacarpal neck fracture

21

Anger superiority effect for change detection and change blindness

22

Anger suppression mediates the relationship between optimism and natural killer cell cytotoxicity in men treated for localized prostate cancer

23

Anger symptoms and “delinquent” behavior in Tourette syndrome with and without attention deficit hyperactivity disorder

24

Anger types and the use of cigarettes and smokeless tobacco among Native American adolescents

25

Anger, aggression, and risky behavior: a comparison of high and low anger drivers

26

Anger, aggression, risky behavior, and crash-related outcomes in three groups of drivers

27

Anger, Anger Expression, and Suicidal Ideation in Korean Adolescents

28

Anger, Depression, and Anxiety in Cardiac Patients: The Complexity of Individual Differences in Psychological Risk

29

Anger, depression, and coping interactions in headache activity and adjustment: a controlled study

30

Anger, hostility, and male perpetrators of intimate partner violence: A meta-analytic review

31

Anger, negative emotions, and cardiovascular reactivity during interpersonal conflict in women

32

Anger, over-control and serious violent offending

33

Anger, psychopathology and cognitive inhibition: a study of UK servicemen

34

Anger, Suppressed Anger, and Risk of Adverse Events in Patients With Coronary Artery Disease

35

Anger-associated panic attacks in Cambodian refugees with PTSD; a multiple baseline examination of clinical data

36

Anger-in and hostility in myocardial infarction patients

37

Anger-Induced T-Wave Alternans Predicts Future Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators

38

Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines

39

Anggaran dan Ciri Fizikokimia Sisa Buangan Makanan di Bandar Baru Bangi

40

angian lattice boltzmann method for euler equati

41

Angina 1 year after percutaneous coronary intervention: A report from the NHLBI Dynamic Registry

42

Angina and origin of three major coronary arteries from independent ostia in right coronary sinus

43

Angina and sudden cardiac death caused by anomalous right coronary artery origin from above the left coronary cusp

44

Angina bullosa hemorrhagica: an idiopathic intraoral blistering disorder

45

Angina caused by coronary steal phenomenon

46

Angina caused by systolic compression of the left coronary artery as a result of pseudoaneurysm of the mitral-aortic intervalvular fibrosa

47

Angina for 14 years

48

Angina Pectoris and Atherosclerotic Risk Factors in the Multisite Cardiac Lifestyle Intervention Program

49

Angina pectoris and myocardial infarction with the use of leuprolife acetate

50

Angina pectoris caused by coronary microvascular spasm

51

Angina pectoris caused by microvascular spasm

52

Angina pectoris caused by microvascular spasm

53

Angina Pectoris or Myocardial Infarctions, Pulmonary Arteriovenous Malformations, Hereditary Hemorrhagic Telangiectasia, and Paradoxical Emboli

54

Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling Original Research Article

55

Angina pectoris: a headache

56

Angina reassessed: pain or protector?

57

Angina Self-Management Plan and Quality of Life, Anxiety and Depression in Post Coronary Angioplasty Patients

58

Angina symptoms in men and women with stable coronary artery disease and evidence of exercise-induced myocardial perfusion defects

59

Angina-Induced Protection Against Myocardial Infarction in Adult and Elderly Patients: Loss of Preconditioning Mechanism in the Aging Heart?

60

Anginal Status and Prediction of Cardiac Events in Patients Enrolled in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

61

Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease

62

Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver

63

Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome

64

Angioarrestin mRNA expression in early-stage lung cancers

65

Angio-Associated Migratory Cell Protein and Smooth Muscle Cell Migration in Development of Restenosis and Atherosclerosis

66

Angioblasts in peripheral blood

67

Angiocardiographic findings in patients with biphasic T-wave inversion in precordial leads

68

Angiocardiography and magnetic resonance imaging to assess pulmonary regurgitation in repaired tetralogy of Fallot

69

Angiocentric Nasal T-Cell Lymphoma in a Patient with Idiopathic CD4+ Lymphocytopenia

70

Angiodysplasia: New Look at an Old Conundrum

71

Angiodysplastic lesions as a cause of colonic bleeding in patients with chronic renal disease: is there an association?

72

Angioedema and urticaria as early presentations of a COVID-19 patient: a case report

73

Angioedema Associated With Droperidol Administration, , ,

74

Angioedema Associated with Haloperidol

75

Angioedema associated with sumatriptan administration

76

Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation

77

Angioedema Due to Lamiaceae Allergy

78

Angioedema Due to Lamiaceae Allergy

79

Angioedema in a Patient with C1 Esterase Inhibitor Deficiency

80

Angioedema related to the ue of hyaluronidae in cataract urgery

81

Angioedema. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society (PTD) and Polish Society of Allergology (PTA)

82

Angioembolization as an effective alternative for hemostasis in intractable life-threatening maxillofacial trauma hemorrhage: case study

83

Angioembolization in itractable epistaxis — a tertiary care experience

84

Angioemboliziation of Internal Pudendal Artery for Treatment of Long Lasting Gross Hematuria After Transurethral Resection of the Prostate

85

Angiofibroma of the Nasal Septum

86

Angiofollicular lymph node hyperplasia (Castlemanʹs disease)

87

Angiogenèse et radiothérapie : tout ce qu’un oncologue radiothérapeute doit savoir

88

Angiogenesis and anti-angiogenesis in hepatocellular carcinoma

89

Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma

90

Angiogenesis and breast cancer

91

Angiogenesis and breast cancer metastasis

92

Angiogenesis and chronic disease

93

Angiogenesis and functional recovery demonstrated after minor stroke

94

Angiogenesis and growth factor expression in a model of transmyocardial revascularization

95

Angiogenesis and growth factor modulation induced by alternagin C, a snake venom disintegrin-like, cysteine-rich protein on a rat skin wound model

96

Angiogenesis and hepatocellular carcinoma

97

Angiogenesis and intrauterine growth restriction

98

Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches

99

Angiogenesis and Mast Cells Density in Oral and Esophageal Squamous Cell Carcinomas

100

Angiogenesis and Minimal Residual Disease in Patients with Acute Myeloid Leukemia

101

Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancer

102

Angiogenesis and Morphometry of Bovine Placentas in Late Gestation from Embryos Produced In Vivo or In Vitro

103

Angiogenesis and musculogenesis as two facets of inflammatory post-ischemic tissue regeneration

104

Angiogenesis and Nitric Oxide in Elderly Men after Continuous and Interval Aerobic Training

105

Angiogenesis and placental growth in normal and compromised pregnancies

106

Angiogenesis and Tumor-Associated Macrophages in Different Grades of Oral Squamous Cell Carcinoma, Verrucous Carcinoma and Epithelial Dysplasia via Immunohistochemical Assessment of Expression of CD34 and CD68 Markers

107

Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum

108

Angiogenesis as targeted breast cancer therapy

109

Angiogenesis assays

110

ANGIOGENESIS EFFECTS OF CHINESE HERBAL SALVIA MILTIORRHIZA AFTER ACUTE MYOCARDIAL INFARCTION IN RATS

111

Angiogenesis factor in endometrial carcinoma: A new prognostic indicator?, ,

112

Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells

113

Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells

114

Angiogenesis in bone fracture healing: A bioregulatory model

115

Angiogenesis in cervical intraepithelial neoplasia and the risk of recurrence, ,

116

Angiogenesis in chronic myelogenous leukaemia

117

Angiogenesis in chronic myelogenous leukaemia

118

Angiogenesis in colon hyperplastic polyp

119

Angiogenesis in ductal breast carcinoma and its correlation with the prognostic parameters

120

Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis

121

Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation

122

Angiogenesis in ischemic human myocardium: clinical results after 3 years

123

Angiogenesis in Ischemic Stroke Patients Aged 30 - 80 years at Gatot Subroto Army Central Hospital (RSPAD) Jakarta

124

Angiogenesis in neovascularized free muscle grafts

125

Angiogenesis in odontogenic keratocyst and dentigerous cyst: Evaluation of JunB and VEGF expression

126

ANGIOGENESIS IN OPEN TIBIAL FRACTURES: A COMPARISON OF MUSCLE AND FASCIOCUTANEOUS FLAPS

127

Angiogenesis in ovarian cancer

128

Angiogenesis in ovarian follicular and luteal development

129

Angiogenesis in primary and metastatic epithelial ovarian carcinoma, ,

130

Angiogenesis in Rat Ischemic Hindlimb: Role of Human Bone Marrow-Derived Mesenchymal Stem Cells Transplantation

131

Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases

132

ANGIOGENESIS IN TISSUE ENGINEERING

133

Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures

134

Angiogenesis induced by autologous whole bone marrow stem cells seeded on collagen scaffolds in silicone nerve tubes. An experimental study

135

Angiogenesis induced by urothelial cells (HCV-29) and their v-ras and v-raf transfectants

136

Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: History and rationale

137

Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation

138

Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers Original Research Article

139

Angiogenesis inhibitors derived from thalidomide

140

Angiogenesis Is Enhanced in Ischemic Canine Myocardium by Transmyocardial Laser Revascularization

141

Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction

142

Angiogenesis modulatory activity of SC-CO2 leaf extract of guyabano (Annona muricata Linn.) using chick embryo chorioallantoic membrane assay

143

Angiogenesis of the ovary,

144

Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation

145

Angiogenesis with recombinant fibroblast growth factor-2 for claudication

146

Angiogenesis with recombinant fibroblast growth factor-2 for claudication

147

ANGIOGENESIS WITHIN ATHEROSCLEROTIC LESIONS BY STEM/PROGENITOR CELLS

148

Angiogenesis, Arteriogenesis, and Diabetes: Paradigm Reassessed?

149

Angiogenesis, myogenesis and cell therapy I

150

Angiogenesis, Myogenesis, and Cell Therapies

151

Angiogenesis, tumor necrosis factor-α and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease

152

Angiogenesis/myogenesis cell therapy

153

Angiogenesis/myogenesis/cell therapy II

154

Angiogenesis: A Critical Role in Locally Aggressive Behavior of Keratocystic Odontogenic Tumor

155

Angiogenic activitiy of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT)

156

Angiogenic activity in the sera of patients with post-kidney transplant erythrocytosis

157

Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice

158

Angiogenic Effect of Leptin in the Quail Chorioallantoic Membrane

159

Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro

160

Angiogenic effect of prostaglandin I 2 in relation with its effect on PPAR nuclear receptors

161

Angiogenic effect of the aqueous extract of Cynodon dactylon on human umbilical vein endothelial cells and granulation tissue in rat

162

ANGIOGENIC EFFECTS OF A NEW HMG-COA REDUCTASE INHIBITOR, PITAVASTATIN

163

Angiogenic Effects of Aerobic Training and Royal Jelly Consumption with Emphasis on the Role of miR-126 and miR-210 in the Aortic Artery of Ovariectomized Diabetic Rats

164

Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis

165

Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells

166

Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease

167

Angiogenic growth factors in human dentine matrix

168

Angiogenic growth factors released in human dental pulp following orthodontic force

169

Angiogenic induction and cell migration in an orthopaedically expanded maxillary suture in the rat

170

Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma

171

Angiogenic response induced by acellular femoral matrix in vivo

172

Angiogenic responses are enhanced in mechanically and microscopically characterized, microbial transglutaminase crosslinked collagen matrices with increased stiffness

173

Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction

174

Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: An experimental study

175

Angiogenin and osteopontin and coronary collateral circulation

176

Angiogenin plasma levels during pregnancy

177

Angiogenin: A marker for preterm delivery in midtrimester amniotic fluid, , , ,

178

Angiograph image restoration with the use of rule base fuzzy 2D Kalman filter

179

Angiographic 5-year follow-up study of right gastroepiploic artery grafts

180

Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)

181

Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus- and Paclitaxel-Eluting Stents

182

Angiographic Analysis of the Anatomic Relation of Coronary Arteries to Mitral and Tricuspid Annulus and Implications for Radiofrequency Ablation

183

Angiographic analysis of the angioplasty versus rotational atherectomy for the treatment of diffuse in-stent restenosis trial (ARTIST)

184

Angiographic anatomical variation of origin of left circumflex coronary artery in Basrah

185

Angiographic anatomy of the grafted left internal mammary artery

186

Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction tria

187

Angiographic and clinical characteristics associated with the development of q-wave and non-q–wave myocardial infarction in the thrombolysis in myocardial infarction (timi) 14 trial

188

Angiographic and clinical outcome following coronary stenting of small vessels : comparison with coronary stenting of large vessels

189

Angiographic and clinical outcome of mild to moderate nonocclusive unstented coronary artery dissection and the influence on coronary flow velocity reserve

190

Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction

191

Angiographic and clinical outcomes following acute infarct angioplasty on saphenous vein grafts

192

Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis

193

Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations

194

Angiographic and Interventional Radiological Management of Obscure Overt Gastrointestinal Bleeding

195

Angiographic and intravascular ultrasound predictors of in-stent restenosis

196

Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: Comparison with same drug-eluting overlapping stents

197

Angiographic and Magnetic Resonance Imaging Evaluation of In-Hospital Delay in Primary Percutaneous Intervention Delivery on Myocardial Salvage

198

Angiographic and morphologic features of the left ventricle in Ebsteinʹs malformation

199

Angiographic and procedural outcome after coronary angioplasty in high-risk subsets using a decremental diameter (tapered) balloon catheter

200

Angiographic and prognostic implications of an exaggerated exercise systolic blood pressure response and rest systolic blood pressure in adults undergoing evaluation for suspected coronary artery disease

201

Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries

202

Angiographic and volumetric intravascular ultrasound comparison between direct Sirolimus-Eluting stent implantation versus predilation

203

Angiographic aspects of ruptured plaque in patients with acute myocardial infarction: correlation with clinical and laboratory variables

204

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

205

Angiographic assessment of myocardial perfusion in patients with isolated coronary artery ectasia

206

Angiographic changes in saphenous vein grafts are predictors of clinical outcomes

207

Angiographic changes in vein grafts: Stable surrogate or seductive siren?

208

Angiographic Characteristics of Coronary Disease and Postresuscitation Electrocardiograms in Patients With Aborted Cardiac Arrest Outside a Hospital

209

Angiographic characteristics of infarct-related and non-infarct-related stenoses in patients in whom stable angina progressed to acute myocardial infarction, ,

210

Angiographic complications in CADASIL

211

Angiographic complications of primary angioplasty

212

Angiographic coronary artery disease associated with hypertensive heart failure and normal ejection fraction. Insights from a prospective monocenter study

213

Angiographic correlates of “spotty” coronary artery calcium detected by electron-beam computed tomography in patients with normal or near-normal coronary angiograms

214

Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery

215

Angiographic Correlates of Graft Patency and Relationship to Clinical Outcomes

216

Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the bypass angioplasty revascularization investigation study (BARI)

217

Angiographic deterioration of target coronary artery narrowing as a result of percutaneous balloon angioplasty, ,

218

Angiographic embolization for arrest of bleeding after penetrating trauma to the abdomen

219

Angiographic Embolization of a Traumatic Pulmonary Pseudoaneurysm

220

Angiographic Evaluation of Myocardial Perfusion in Patients With Syndrome X

221

Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI

222

Angiographic evaluation of traumatic arterial injuries of the upper limbs: a retrospective study

223

Angiographic Evolution of Intracoronary Thrombus and Dissection Following Percutaneous Transluminal Coronary Angioplasty (The Thrombolysis and Angioplasty in Unstable Angina [TAUSA] Trial)

224

Angiographic Fate of Collateral Vessels After Surgical Revascularization of the Totally Occluded Left Anterior Descending Artery

225

Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary Syndrome

226

Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angin and previous bypass surgery

227

Angiographic features, surgical management and outcomes of proximal middle cerebral artery aneurysms

228

Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry

229

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

230

ANGIOGRAPHIC FINDINGS IN 130 PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE

231

Angiographic findings in Buerger disease

232

Angiographic findings in monozygotic twins with coronary artery disease

233

Angiographic findings in patients undergoing catheterization for recurrent symptoms within 30 days of successful coronary intervention

234

Angiographic findings in tumoral calcinosis

235

Angiographic Findings of Patients with Blunt or Penetrating Extremity Injuries: Focus on Indications and Contraindications

236

Angiographic Findings, Time Course of Regional and Global Left Ventricular Function, and Clinical Outcome in Diabetic Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Transluminal Coronary Angioplasty

237

Angiographic Follow-up of Internal Thoracic Artery for Free Bypass Grafting

238

Angiographic follow-up results of STent versus Atherectomy Randomized Trial (START)

239

Angiographic Lesion Severity and Subsequent Myocardial Infarction

240

Angiographic Localization of Potential Culprit Coronary Arteries in Patients With Interatrial Block Following a Positive Exercise Tolerance Test

241

Angiographic methods to assess human coronary angiogenesis

242

Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction

243

Angiographic Outcomes With Early Eptifibatide Therapy in Non–ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial)

244

Angiographic Patency of the Radial Artery Conduit in Coronary Artery Bypass Grafting

245

Angiographic Pattern of Restenosis Following Implantation of Overlapping Sirolimus-Eluting (Cypher) Stents

246

Angiographic Patterns of Drug-Eluting Stent Restenosis and One-Year Outcomes After Treatment With Repeated Percutaneous Coronary Intervention

247

Angiographic patterns of restenosis after paclitaxel-eluting stent implantation

248

Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction

249

Angiographic plaque complexity: the tip of the unstable plaque iceberg

250

Angiographic Predictors and Clinical Outcome of Acute Side Branch Occlusion after Coronary Artery Stent Implantation

251

Angiographic Predictors of 6-Month Patency of Bypass Grafts Implanted to the Right Coronary Artery: A Prospective Randomized Comparison of Gastroepiploic Artery and Saphenous Vein Grafts Original Research Article

252

Angiographic predictors of adverse outcomes in the modern interventional era

253

Angiographic predictors of graft patency and disease progression after coronary artery bypass grafting with arterial and venous grafts

254

Angiographic predictors of neointimal thickening after successful coronary wall healing following percutaneous revascularization

255

Angiographic predictors of new coronary occlusions

256

Angiographic Predictors of Recurrent Stent Thrombosis (from the Outcome of PCI for Stent-ThrombosIs MultIcentre STudy [OPTIMIST])

257

Angiographic predictors of reocclusion after thrombolysis: Results from the thrombolysis in myocardial infarction (TIMI) 4 trial

258

Angiographic presence of myocardial bridge after successful percutaneous transluminal coronary angioplasty

259

Angiographic presentation of coronary artery spasm in heart transplant recipients

260

Angiographic profile in patients with congenital anomalous origin of the coronary arteries

261

Angiographic restenosis rate in patients with chronic total occlusions and subtotal stenoses after initially successful intracoronary stent placement

262

Angiographic results after the use of a sutureless aortic connector for proximal vein graft anastomoses

263

Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)

264

Angiographic Results of the First Human Experience With the Biolimus A9 Drug-Eluting Stent for De Novo Coronary Lesions

265

Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia

266

Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus

267

Angiographic severity and extent of coronary artery disease in type 1 diabetes

268

Angiographic severity of coronary artery disease in patients with metabolic syndrome

269

Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis

270

Angiographic significance of a discordant ST-segment elevation of ≥5 millimeters in patients with ventricular-paced rhythm and acute myocardial infarction

271

Angiographic Stent Thrombosis After Routine Use of Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: The Importance of Thrombus Burden Original Research Article

272

Angiographic study of aorta, coronary arteries, and left ventricular performance after neonatal arterial switch operation for simple transposition of the great arteries, ,

273

Angiographic study of Moyamoya disease and histological study in the external carotid artery system

274

Angiographic Surrogate End Points in Drug-Eluting Stent Trials: A Systematic Evaluation Based on Individual Patient Data From 11 Randomized, Controlled Trials Original Research Article

275

Angiographic variables predict increased riskfor adverse ischemic events after coronarystenting with glycoprotein IIb/IIIa inhibition: Results from the TARGET trial

276

Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation

277

Angiographic, intravascular ultrasound and functional findings early after orthotopic heart transplantation

278

Angiographic, ultrasonic, and angioscopic assessment of the coronary artery wall and lumen area configuration after directional atherectomy: The mechanism revisited

279

Angiographical and computed tomographic findings in diffuse pulmonary arteriovenous fistulas

280

Angiographical study of ramus intermedius coronary artery in Basrah

281

Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing

282

Angiographically evident atherosclerotic stenosis associated with myocardial bridging and risk factors for the artery stenosis located proximally to myocardial bridging

283

Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemi and familial combined hyperlipidemia: Correlation with high density lipoproteins

284

Angiographically silent left main disease detected by intravascular ultrasound: a marker for future adverse cardiac events

285

Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours

286

Angiography and interventional cardiology

287

Angiography and interventional cardiology Review Article

288

Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction

289

Angiography of potential cardiac donors

290

Angiography versus intravascular ultrasound assessment of coronary stent placement: observations from the AVID study

291

Angiography; an Inducer of TGF-Β during Early Atherosclerosis

292

Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients

293

Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients

294

Angioid streaks and other ocular complications of Pagetʹs disease of bone

295

Angioimmunoblastic lymphadenopathy-like T-cell lymphoma A case report and immunologic study

296

Angiokeratoma corporis diffusum without systemic features in a young Kashmiri female: a rare occurrence

297

Angioleiomyoma in the tonsil: an uncommon tumour in a rare site

298

Angioleiomyoma of the diaphragm

299

Angioleiomyoma of the Hand: A Case Series and Review of the Literature

300

Angioleiomyoma: a benign tumor with karyotypic aberrations

301

Angiolipoma of the breast with microcalcification: Mammographic, sonographic, and histologic appearances

302

Angiolymphoid hyperplasia with eosinophilia

303

Angiolymphoid hyperplasia with eosinophilia

304

ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA – A RARE ENTITY

305

Angioma serpiginosum successfully treated by a single session of intense pulsed light therapy

306

Angiomagnetic resonance imaging of iliofemorocaval venous thrombosis

307

Angiomatoid fibrous histiocytoma in mediastinum

308

Angiomatoid Fibrous Histiocytoma, A Great Mimicker – A Short Series of 3 Cases with EWSR1 Fusion

309

Angiomyofibroblastoma mimicking an inguinal hernia: a challenging diagnosis in a male patient

310

Angiomyofibroblastoma of the Vaginal Portion

311

Angiomyofibroblastoma of the Vulva

312

Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair

313

Angiomyolipoma and Malignant PEComa: Discussion of TwoRare Adrenal Tumors

314

Angiomyolipoma of the Adrenal Gland: A Case Report

315

Angiomyoma of the Hard Palate

316

Angiomyxolipoma; Report of a new case in subcutaneous tissue and review of the literature

317

Angiomyxoma Presenting as an Unusual Vaginal Mass

318

Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis

319

Angioneogenesis in rheumatoid arthritis

320

Angioneogenesis in rheumatoid arthritis

321

ANGIOPEPTIDES: NOVEL PEPTIDES THAT INDUCE ANGIOGENESIS

322

ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES

323

ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES

324

Angioplasty and stenting of the distal coronary anastomosis for graft failure immediately after coronary artery bypass grafting

325

Angioplasty for acute myocardial infarction in community hospital without surgical back-up: Response to Wharton and Angelini publications “should guidelines be changed?: Not whether but when”

326

Angioplasty for coarctation in different aged patients

327

Angioplasty for intermittent claudication

328

Angioplasty for lower-limb ischaemia: time for randomised controlled trials

329

Angioplasty for the late stent thrombosis, the new technical challenge: A single centre experience

330

Angioplasty Guidewire Velocity: A New Simple Method to Calculate Absolute Coronary Blood Velocity and Flow

331

Angioplasty in the stent era: results of a consecutive series of patients undergoing coronary angioplasty without surgical backup

332

Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA

333

Angioplasty of a left anterior descending artery originating from the right sinus of Valsalva (discussion in decision making)

334

Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function

335

Angioplasty of complex lesions in ischemic rest angina: Results of the Thrombolysis and Angioplasty in Unstable Angin (TAUSA) Trial

336

Angioplasty of the internal thoracic artery bypass-graft an alternative to reoperation

337

Angioplasty or Surgery for Multivessel Coronary Artery Disease: Comparison of Eligible Registry and Randomized Patients in the EAST Trial and Influence of Treatment Selection on Outcomes

338

Angioplasty through a stent side door

339

Angioplasty versus bypass surgery

340

Angioplasty versus bypass surgery

341

Angioplasty versus bypass surgery

342

Angioplasty versus intravenous thrombolysis for acute myocardial infarction

343

Angioplasty vs medical therapy in the treatment of unilateral atherosclerotic renal artery stenosis: A prospective randomized open blinded-endpoint trial

344

Angioplasty, inflammation, and antiplatelet agents

345

Angioplasty-induced superoxide anions and neointimal hyperplasia in the rabbit carotid artery: suppression by the isoflavone trans-tetrahydrodaidzein

346

Angiopoietin 2 Level in Type 2 Diabetic Patients with Cardiovascular Complications

347

Angiopoietin like protein 3 (Angptl3), fatty acid binding protein 4 (FABP4) and homeostasis model assessment of insulin resistance (HOMA-IR) among Indonesian obese non diabetic males

348

ANGIOPOIETIN-1 AND -2 MEDIATE PROINFLAMMATORY RESPONSES IN HUMAN ENDOTHELIAL CELLS

349

Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis

350

Angiopoietin-1 supports induction of hematopoietic activity in human CD34− bone marrow cells

351

Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation

352

ANGIOPOIETIN-2 IS AN AUTOCRINE REGULATOR OF ENDOTHELIAL CELL RESPONSIVENESS AND VASCULAR HOMEOSTASIS

353

Angiopoietin-like 4 Protein Elevates the Prosurvival Intracellular O2−:H2O2 Ratio and Confers Anoikis Resistance to Tumors

354

Angiopoietin-like protein 2 in psoriasis: a new linkage with metabolic syndrome

355

Angiopoietin-like protein 8 (betatrophin) may inhibit hepatocellular carcinoma through suppressing of the Wnt signaling pathway

356

Angiopoietin-like proteins: Another player in the metabolic field

357

Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy

358

Angiopoietin-like-4 is a potential angiogenic mediator in arthritis

359

Angiopoietins in angiogenesis

360

Angiopoietins in malignancy

361

Angiopoietins: a link between angiogenesis and inflammation

362

Angiosarcoma after conservative treatment and radiation therapy for adenocarcinoma of the breast

363

Angiosarcoma as a sequela of breast cancer treatment with lumpectomy and radiotherapy

364

Angiosarcoma at Dialysis Fistula Site in a Patient on Continuous Ambulatory Peritoneal Dialysis

365

Angiosarcoma in the right atria demonstrated by fusion images of multislice computed tomography and positron emission tomography using F-18 Fluoro-Deoxyglucose

366

Angiosarcoma of Kidney A Case Report and Review of Literature

367

Angiosarcoma of the breast after quadrantectomy and postoperative radiotherapy for carcinoma

368

Angiosarcoma of the breast: a 30 year perspective with an optimistic outlook

369

Angiosarcoma of the chest wall

370

Angiosarcoma of the Liver Presenting with Esophageal Bleeding and Arterio-portal Shunts

371

Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy

372

Angiosarcoma of the pericardium presenting as hemorrhagic pleuropericarditis, cardiac tamponade, and thromboembolic phenomena

373

Angiosarcoma of the Right Atrium with Extension to SVC and IVC Presenting with Complete Heart Block and Significant Pericardial Effusion

374

Angiosarcoma of the right atrium: A diagnostic dilemma

375

Angiosarcoma of the small intestine

376

Angiosarcoma: complication of breast conservation treatment

377

Angiosarcome mammaire primitif : à propos de deux cas

378

Angioscopic and Virtual Histology Intravascular Ultrasound Characteristics of Culprit Lesion Morphology Underlying Coronary Artery Thrombosis

379

Angioscopic Assessment of Coronary Lesions Underlying Thrombus

380

Angioscopic characteristics of coronary narrowing in patients with recurrent myocardial ischemia after myocardial infarction

381

Angioscopic Comparison of Neointimal Coverage Between Zotarolimus- and Sirolimus-Eluting Stents

382

Angioscopic Coronary Macromorphology After Thrombolysis in Acute Myocardial Infarction

383

Angioscopic detection of residual pulmonary thrombi in the differential diagnosis of pulmonary embolism

384

Angioscopic evaluation of angiographically complex coronary lesions,

385

Angioscopic evaluation of atherosclerotic plaques: Validation by histomorphologic analysis and association with stable and unstable coronary syndromes

386

Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent

387

Angioscopic Evaluation of Rotational Atherectomy Followed by Additional Balloon Angioplasty Versus Balloon Angioplasty Alone in Coronary Artery Disease: Prospective, Randomized Study

388

Angioscopic findings during coronary angioplasty of coronary occlusions

389

Angioscopic findings of delayed healing at sites of sirolimus-eluting stent overlap after 21-month implantation

390

Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions Original Research Article

391

Angioscopic identification of coronary thrombus in patients with postinfarction angina

392

Angioscopic versus angiographic detection of thrombus during coronary interventional procedures

393

Angioscopy of Culprit Coronary Lesions in Unstable Angina Pectoris and Correlation of Clinical Presentation With Plaque Morphology

394

Angioscopy variables predictive of early angiographic outcome after excimer laser-assisted coronary angioplasty

395

Angioseal use after antegrade femoral arteriotomy in patients undergoing percutaneous revascularization for critical limb ischemia: A case series

396

Angiosome-targeted isolated tibial angioplasty for healing of ischemic foot ulcer: a retrospective study

397

Angiosperm DNA contamination by endophytic fungi: Detection and methods of avoidance

398

Angiosperms (seagrass) within the EU water framework directive: A UK perspective

399

Angiostrongylus eosinophilic meningitis in Egypt

400

Angiostrongylus vasorum from South America and Europe represent distinct lineages

401

Angiotenin II and vacular endothelial growth factor in the vitreou fluid of patient with diabetic macular edema and other retinal diorder

402

Angiotensin (1–7) and Apelin co-therapy: New strategy for heart failure treatment of rats

403

Angiotensin (1-7) Inhibits Ang II-mediated ERK1/2 Activation by Stimulating MKP-1 Activation in Vascular Smooth Muscle Cells

404

Angiotensin 1-7 Administration Increases Renal Blood Flow in the Absence of Bradykinin B2 Receptor in Ovariectomized Estradiol Treated Rats: The Role of Mas Receptor

405

Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference

406

Angiotensin 2 type 1 receptor blocker attenuates atrial structural remodeling in spontaneously hypertensive rats: Role of the suppression of atrial oxidative stress

407

Angiotensin and asymmetric fetal growth

408

Angiotensin and vascular fibrinolytic balance

409

Angiotensin antagonists and renal ischemia/reperfusion: Possible modulation by L-carnitine

410

Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade

411

Angiotensin blockade for hypertension: a promise fulfilled

412

Angiotensin Blockade Inhibits Increased JNKs, AP-1 and NF- κ B DNA-binding Activities in Myocardial Infarcted Rats

413

Angiotensin Blockade Inhibits SIF DNA Binding Activities via STAT3 after Myocardial Infarction

414

Angiotensin converting enzyme (ACE D/I) polymorphism and its relation to liver fibrosis progression in Egyptian patients with chronic hepatitis C virus infection

415

Angiotensin Converting Enzyme (ACE) Activity Levels in Insulin-independent Diabetes Mellitus and Effect of ACE levels on Diabetic Patients with Nephropathy

416

Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease

417

Angiotensin converting enzyme (ACE) gene expression in experimentally induced liver cirrhosis in rats

418

Angiotensin converting enzyme (ACE) inhibitory, antihypertensive and antihyperlipidaemic activities of protein hydrolysates from Rhopilema esculentum

419

Angiotensin Converting Enzyme and Myofibroblasts during Tissue Repair in the Rat Heart

420

Angiotensin converting enzyme gene — a candidate gene for addiction to smoking?

421

Angiotensin Converting Enzyme Gene I/D Polymorphism in Pakistani Rheumatic Heart Disease Patients and Healthy Controls

422

Angiotensin converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension, and childhood blood pressure

423

Angiotensin Converting Enzyme Gene Insertion/Deletion Variant and Familial Mediterranean Fever-related Amyloidosis

424

Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension

425

Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease

426

Angiotensin Converting Enzyme Gene Polymorphism in Aizheimers Disease

427

Angiotensin Converting Enzyme Gene Polymorphism in Essential Hypertension Based on Ambulatory Blood Pressure Monitoring

428

Angiotensin Converting Enzyme Gene Polymorphism in Iranian Patients with Type 2 Diabetes

429

Angiotensin Converting Enzyme Gene Polymorphism Is Not Related to Essential Hypertension in a Greek Population

430

Angiotensin Converting Enzyme I/D Polymorphism and Chronic Hepatitis C Virus Infection

431

Angiotensin Converting Enzyme I/D Polymorphism in Egyptian Patients with Type 2 Diabetes Mellitus

432

Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension

433

Angiotensin converting enzyme inhibition by captopril influences cardiac work in healthy hearts

434

Angiotensin Converting Enzyme Inhibition Corrects Na+/H+ Exchanger Overactivity in Essential Hypertension

435

Angiotensin converting enzyme inhibition, with quinapril, improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND study (trial on reversing endothelial dysfunction)

436

Angiotensin converting enzyme inhibitor as an additive treatment after successful balloon dilation of a critical pulmonary valve stenosis

437

Angiotensin converting enzyme inhibitor captopril does not improve exercise tolerance or reduce exercise induced myocardial ischemi in patients with angin pectoris

438

Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese

439

Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death

440

ANGIOTENSIN CONVERTING ENZYME- INHIBITORS ASSOCIATED COUGH: A PROSPECTIVE EVALUATION IN HYPERTENSIVES

441

Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection

442

Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism: An Observational Study among Diabetic Hypertensive Subjects in Malaysia

443

Angiotensin- Converting Enzyme Insertion/Deletion Polymorphism and Its Association with Coronary Artery Disease in an Iranian Population

444

Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimerʹs disease and longevity

445

Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan: Ethnic difference of ACE genotype

446

Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis

447

Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris

448

Angiotensin I Converting Enzyme Gene Polymorphism in Chinese Patients With Hypertension

449

Angiotensin I Converting Enzyme Inhibitory Activities of Hydroalcoholic Extracts of Nardostachys jatamansi, Prangos ferulacea and Marrubium vulgare

450

Angiotensin I Modulates Ca-transport Systems in the Rat Heart Through Angiotensin II

451

Angiotensin I retention behavior on Butyl-Sepharose under linear loading chromatographic conditions

452

Angiotensin I-Converting Enzyme (ACE) Gene Polymorphism in Relation to Physical Performance, Cognition and Survival—A Follow-up Study of Elderly Danish Twins

453

Angiotensin I–converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene

454

Angiotensin I-converting enzyme (ACE) inhibitory activities of sardinelle (Sardinella aurita) by-products protein hydrolysates obtained by treatment with microbial and visceral fish serine proteases

455

Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion

456

Angiotensin I–converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort

457

Angiotensin I–converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women

458

Angiotensin I-Converting Enzyme Gene Polymorphism and Acute Response to Captopril in Essential Hypertension

459

Angiotensin I-converting enzyme gene polymorphism in a low-risk European population for coronary artery disease Original Research Article

460

Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactor

461

Angiotensin I-converting enzyme inhibitory compounds in white and red wines

462

Angiotensin I-converting enzyme inhibitory oligo-tyrosine peptides synthesized by α-chymotrypsin

463

Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats

464

Angiotensin I-converting enzyme inhibitory peptides in douchi, a Chinese traditional fermented soybean product

465

Angiotensin I-converting enzyme inhibitory properties of lentil protein hydrolysates: Determination of the kinetics of inhibition

466

Angiotensin I–converting enzyme insertion/insertion genotype as a genetic risk factor for cardiovascular disease

467

Angiotensin I-converting enzyme-inhibitory peptide fractions from albumin 1 and globulin as obtained of amaranth grain

468

Angiotensin II (Ang II) stimulates sympathetic nerve (SNS) activity through activation of oxidative stress

469

Angiotensin II (AngII) activates nuclear factor-κB via AT1 and AT2 receptors in the kidney

470

Angiotensin II activates intermediate-conductance Ca2+-activated K+ channels in arterial smooth muscle cells

471

Angiotensin II Activates Stat5 Through Jak2 Kinase in Cardiac Myocytes

472

Angiotensin II activation of Src mediates ERK stimulation in human vascular smooth muscle cells

473

Angiotensin II and atherosclerosis

474

Angiotensin II and cardiomyocyte apoptosis in the SHR

475

Angiotensin II and Intracellular Calcium of Adult Cardiac Fibroblasts

476

Angiotensin II and the pathophysiology of cardiovascular remodeling

477

Angiotensin II and trials of cardiovascular outcomes

478

Angiotensin II antagonists block ethanol effects on the aerial righting reflex

479

Angiotensin II antagonists demonstrate greater long-term persistence versus other antihypertensive medications

480

Angiotensin II antagonists for hypertension: are there differences in efficacy?

481

Angiotensin II antagonists for hypertension: there are differences in efficacy

482

Angiotensin II antagonists for hypertension: there are differences in efficacy: The reply

483

Angiotensin II AT1 Receptor Blockade Improves Renal Perfusion in Hypercholesterolemia

484

Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys

485

Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension

486

Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis

487

Angiotensin II Differentially Induces Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Production and Disturbs MMP/TIMP Balance

488

Angiotensin II directly inhibits protein synthesis in murine myotubes

489

Angiotensin II Elevates Nitric Oxide Synthase 3 Expression and Nitric Oxide Production Via a Mitogen-Activated Protein Kinase Cascade in Ovine Fetoplacental Artery Endothelial Cells

490

Angiotensin II enhances cardiac Na+/Ca2+ exchanger current via an autocrine release of endothelin

491

Angiotensin II Enhances the Expression of Giα in A10 Cells (Smooth Muscle): Relationship with Adenylyl Cyclase Activity

492

Angiotensin II increases expression and secretion of cathepsin F in cultured human monocyte-derived macrophages: An angiotensin II type 2 receptor-mediated effect

493

Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: A mechanism by which angiotensin II antagonizes cGMP signaling

494

Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway

495

Angiotensin II increases the release of endothelin-I from human cultured endothelial cells but does not regulate its circulating levels

496

Angiotensin II induced hyperplasia and hypertrophy in human vascular smooth muscle cells are mediated via AT1 receptors

497

Angiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro

498

Angiotensin II induces DNA injury in human umbilical artery smooth muscle cells via a mechanism which involves hydrogen peroxide

499

Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice

500

Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptor

501

Angiotensin II induces mitochondrial dysfunction and promotes apoptosis via JNK signalling pathway in primary mouse calvaria osteoblast

502

Angiotensin II Induces Nuclear Factor- κ B Activation in Cultured Neonatal Rat Cardiomyocytes Through Protein Kinase C Signaling Pathway

503

Angiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cells

504

Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice

505

Angiotensin II inhibition and prevention of atrial fibrillation and stroke

506

Angiotensin II inhibition during myocardial ischemia–reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction

507

Angiotensin II inhibition of Ca2+ currents is independent of ATR1 angiotensin II receptor activation in rat adult vagal afferent neurons

508

Angiotensin II Inhibits Insulin-Induced egr-1 Expression in Mesangial Cells

509

Angiotensin II inhibits the forearm vascular response to increased arterial pressure in humans

510

Angiotensin II Mechanisms in Ischemic Heart Disease: Pathophysiology and Survival

511

Angiotensin II mechanisms in the renal responses to hypertension and diabetes mellitus.

512

Angiotensin II Modulates ANP-R2/ANP-C Receptor-mediated Inhibition of Adenylyl Cyclase in Vascular Smooth Muscle Cells: Role of Protein Kinase C

513

Angiotensin II Plays a Critical Role in Alcohol-Induced Cardiac Nitrative Damage, Cell Death, Remodeling, and Cardiomyopathy in a Protein Kinase C/Nicotinamide Adenine Dinucleotide Phosphate Oxidase–Dependent Manner

514

Angiotensin II Plays an Important Role in Maintaining Blood Pressure in Postmenopausal Women Receiving Hormone Replacement Therapy

515

Angiotensin II Potentiates DNA Synthesis in AT-1 Transformed Cardiomyocytes

516

Angiotensin II promotes ICAM-1 expression in vitro and soluble ICAM-1 secretion in vivo

517

Angiotensin II receptor antagonism does not prevent tolerance to continuous transdermal nitroglycerin

518

Angiotensin II Receptor Antagonist Blocks the Expression of Connexin43 Induced by Cyclical Mechanical Stretch in Cultured Neonatal Rat Cardiac Myocytes

519

Angiotensin II receptor antagonists Review Article

520

Angiotensin II receptor blockade and end-organ protection

521

Angiotensin II receptor blockade by losartan reduces the incidence of heart failure after an MI in rat

522

Angiotensin II receptor blockade does not improve left ventricular function andremodeling in subacute mitral regurgitation in the dog

523

Angiotensin II receptor blockade in diabetic nephropathy

524

Angiotensin II receptor blockade in diabetic nephropathy

525

Angiotensin II receptor blockade reduces expression of basic fibroblast growth factor mRNA in the balloon injured rat carotid artery. Quantification by competitive polymerase chain reaction

526

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study Original Research Article

527

ANGIOTENSIN II RECEPTOR BLOCKER VALSARTAN ENHANCES GLUCOSE-INDUCED INSULIN SECRETION

528

Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation

529

Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension

530

Angiotensin II Receptor Blockers Downsize Adipocytes in Spontaneously Type 2 Diabetic Rats With Visceral Fat Obesity

531

Angiotensin II receptor blockers: review of the binding characteristics

532

Angiotensin II Receptor Subtypes and Biological Responses in the Rat Heart

533

Angiotensin II Receptor Type 1 mRNA is Upregulated in Atria of Patients with End-stage Heart Failure

534

Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease Original Research Article

535

Angiotensin II reduces alcohol intake and choice in water- or food-restricted rats

536

Angiotensin II regulates AT2 subtype receptor promoter activity and expression in rat primary endothelial cell

537

Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR

538

Angiotensin II Release From Rabbit Intrarenal Arteries: A Critical Assessment

539

Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via JAK-STAT pathway

540

Angiotensin II Stimulated Expression of Transforming Growth Factor-β1in Cardiac Fibroblasts and Myofibroblasts

541

Angiotensin II stimulates cardiac chloride/bicarbonate exchange activity by phosphorylation of serine 67 of AE3

542

Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure

543

Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure

544

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins Original Research Article

545

Angiotensin II stimulates phosphorylation and nuclear accumulation of R-Smad 2 in cultured cardiac fibroblasts: T-type Ca channel blockade in vascular smooth muscle cells causes G1S cell cycle arrest

546

Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties

547

Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non–insulin-dependent diabetes mellitus

548

Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide

549

Angiotensin II type 1 receptor (A1166C) gene polymorphism in Egyptian adult hemodialysis patients

550

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

551

Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer

552

Angiotensin II Type 1 Receptor Blockade Abolishes Specific KATPChannel Gene Expression in Rats with Myocardial Ischemia

553

Angiotensin II type 1 receptor blockade improves cardiac expression of hsp72 and tolerance against ischemia/reperfusion injury in insulin resistance rat

554

Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model

555

Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice

556

Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study

557

Angiotensin II Type 1 Receptor Gene A1166C Polymorphism Was Not Associated With Acute Coronary Syndrome in an Iranian Population

558

Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome

559

Angiotensin II Type 1 Receptor Gene Polymorphism Is Associated With Increase of Left Ventricular Mass But Not With Hypertension

560

Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events

561

Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation

562

Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists

563

Angiotensin II type-I receptor antagonists in the treatment of heart failure

564

Angiotensin II upregulates transforming growth factor-β type I receptor on rat vascular smooth muscle cells

565

Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension

566

Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart

567

Angiotensin II, VEGF, and diabetic retinopathy

568

Angiotensin II, VEGF, and diabetic retinopathy

569

Angiotensin II, VEGF, and diabetic retinopathy

570

Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A2-mediated release of arachidonic acid

571

Angiotensin II-induced C-reactive protein generation: Inflammatory role of vascular smooth muscle cells in atherosclerosis

572

Angiotensin II-induced ionic currents and signalling pathways in submandibular ganglion neurons

573

Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

574

Angiotensin II-Mediated apoptosis and P53 expression in human cardiomyocytes

575

Angiotensin II-mediated Growth and Antigrowth Effects in Cultured Neonatal Rat Cardiac Myocytes and Fibroblasts

576

Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma

577

Angiotensin receptor antagonists

578

Angiotensin receptor antagonists: focus on losartan

579

Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome

580

Angiotensin receptor blockade improves myocardial beta-adrenergic receptor signaling in postinfarction left ventricular remodeling: A possible link between beta-adrenergic receptor kinase-1 and protein kinase C epsilon isoform Original Research Article

581

Angiotensin Receptor Blocker and N-Acetyl Cysteine for Reduction of Proteinuria in Patients With Type 2 Diabetes Mellitus

582

Angiotensin Receptor Blockers – finally the evidence is coming in: IDNT and RENAAL

583

Angiotensin Receptor Blockers and Cardiovascular Protection: Are We ONTARGET?

584

Angiotensin receptor blockers and diuretics as combination therapy: clinical implications

585

Angiotensin Receptor Blockers and Magnesium Status in Essential Hypertension

586

Angiotensin receptor blockers in heart failure: A work in progress

587

Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials

588

Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial

589

Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial

590

Angiotensin Receptor Blockers: Current Status and Future Prospects

591

Angiotensin receptor blockers: how important is selectivity?

592

Angiotensin receptor blockers—finally the evidence is coming in: IDNT and RENAAL

593

Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series

594

Angiotensin Receptor-1 Blocker Inhibits Atherosclerotic Changes and Endothelial Disruption of the Aortic Valve in Hypercholesterolemic Rabbits Original Research Article

595

Angiotensin Receptors in Cardiac and Renal Hypertrophy in Rats

596

Angiotensin receptors: history and mysteries

597

Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis

598

Angiotensin Type 2 Receptor Gene Polymorphisms and Susceptibility to Preeclampsia

599

Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

600

Angiotensin-(1–7) and vasopeptidase inhibition

601

Angiotensin-(1–7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala

602

ANGIOTENSIN, BRADYKININ AND CONVERTING ENZYME IN IMPOSED AND PHYSIOLOGICAL FLOW-RELATED ARTERIAL REMODELING.

603

Angiotensin, fibrinolysis, and vascular homeostasis

604

Angiotensin-Converting Enzyme (ACE) Inhibitor Angioedema: The Silent Epidemic

605

Angiotensin-converting enzyme (ACE) inhibitors revert abnormal right ventricular filling in patients with restrictive left ventricular disease

606

Angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms in generalized aggressive periodontitis

607

Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells

608

angiotensin-converting enzyme 2 (ace2) gene polymorphism in patients with type 2 diabetes (t2dm) in thi-qar, iraq

609

Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy

610

Angiotensin-converting enzyme activity and contractile effects of angiotensin I and II in human uteroplacental arteries

611

Angiotensin-converting enzyme and apolipoprotein B polymorphisms in coronary artery disease

612

Angiotensin-Converting Enzyme and Heart Chymase gene Polymorphisms in Hypertrophic Cardiomyopathy

613

Angiotensin-converting enzyme and p22phox polymorphisms and the risk of coronary heart disease in a low-risk Spanish population

614

Angiotensin-converting Enzyme and Renin Inhibition Activities, Antioxidant Properties, Phenolic and Flavonoid Contents of Cuphea ignea A. DC.

615

Angiotensin-Converting Enzyme Assay Optimization:Influence of Various Buffers and Their Concentrations

616

Angiotensin-converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure

617

Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension

618

Angiotensin-converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: Identifying the guideposts for navigating the genetics landscape

619

Angiotensin-converting enzyme gene polymorphism and common carotid stiffness: The Rotterdam study

620

Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients

621

Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy

622

Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy

623

Angiotensin-Converting Enzyme Gene Polymorphism in Systemic Hypertension

624

Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis

625

Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction

626

Angiotensin-converting enzyme genetic variants do not influence response to risperidone in autistic children

627

Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes

628

Angiotensin-Converting Enzyme Genotype Predicts Cardiac and Autonomic Responses to Prolonged Exercise Original Research Article

629

Angiotensin-Converting Enzyme Genotypes and Risk for Myocardial Infarction in Women

630

Angiotensin-Converting Enzyme I/D Polymorphism in Behçet’s Disease

631

Angiotensin-converting enzyme inhibition after myocardial infarction: the trandolapril cardiac evaluation study

632

Angiotensin-Converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats

633

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet

634

Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients

635

Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium

636

Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation Original Research Article

637

Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function: Ischemia Management with Accupril post–bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the othe

638

Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non–ST-elevation acute coronary syndromes

639

Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling

640

Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction

641

Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane

642

Angiotensin-converting enzyme inhibition to enhance vascular health—clinical and research models

643

Angiotensin-converting enzyme inhibition, autonomic activity, and hemodynamics in patients with heart failure who perform isometric exercise

644

Angiotensin-Converting Enzyme Inhibitor as a Marker, Not a Risk Factor, for Poor Prognosis

645

Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction Original Research Article

646

Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure,

647

Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure

648

Angiotensin-converting enzyme inhibitor dosing in heart failure: What is optimal?

649

Angiotensin-converting enzyme inhibitor for epirubicin-induced dilated cardiomyopathy

650

Angiotensin-converting enzyme inhibitor meta-analysis provides misleading conclusion

651

Angiotensin-Converting Enzyme Inhibitor Prevents Plasminogen Activator Inhibitor-1 Expression in a Rat Model with Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide Synthesis

652

Angiotensin-Converting Enzyme Inhibitor Therapy Affects Left Ventricular Mass in Patients With Ejection Fraction >40% After Acute Myocardial Infarction

653

Angiotensin-Converting Enzyme Inhibitor Therapy at the Time of Coronary Artery Bypass Surgery: When a Friend Turns Mean-Spirited

654

Angiotensin-converting enzyme inhibitor treatment after myocardial infarction: A selective approach for maximum benefit

655

Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarction

656

Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease

657

Angiotensin-converting enzyme inhibitors after myocardial infarction: Indications and timing

658

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease

659

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study

660

Angiotensin-converting enzyme inhibitors and myocardial infarction: A class effect?

661

Angiotensin-Converting Enzyme Inhibitors and Outcome Among Patients With Heart Failure and Renal Insufficiency: Need for a Prospective Study

662

Angiotensin-converting enzyme inhibitors and β-blockers in long-term treatment of dilated cardiomyopathy

663

Angiotensin-converting enzyme inhibitors as a cause of unilateral tongue angioedema in a 68-year-old woman

664

Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy

665

Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation

666

Angiotensin-Converting Enzyme Inhibitors Can Increase the Transvalvular Gradient Among Patients With Aortic Stenosis

667

Angiotensin-converting enzyme inhibitors in adults after the mustard procedure

668

Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease

669

Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Original Research Article

670

Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: A pharmaceutical industry perspective, ,

671

Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials Original Research Article

672

Angiotensin-Converting Enzyme Inhibitors Potentiate Preconditioning Through Bradykinin B2 Receptor Activation in Human Heart

673

Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level

674

Angiotensin-converting enzyme inhibitors reveal non-NO-, non-prostacycline-mediated endothelium-dependent relaxation in internal thoracic artery of hypertensive patients

675

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists and Calcium Channel Blocking Agents: Review of Potential Benefits and Possible Adverse Reactions

676

Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure

677

Angiotensin-converting enzyme inhibitors: a new therapy for atrial fibrillation?

678

Angiotensin-converting enzyme inhibitors: ischemia is not the correct measure of benefit

679

Angiotensin-converting enzyme inhibitors: optimal management of cardiovascular risk

680

Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in General Population of West Azarbaijan, Iran

681

Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris

682

Angiotensin-converting enzyme insertion/deletion polymorphism in angina pectoris with normal coronary arteriograms

683

Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults

684

Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults: Reply

685

Angiotensin-Converting Enzyme-2 Overexpression Improves Left Ventricular Remodeling and Function in a Rat Model of Diabetic Cardiomyopathy

686

Angiotensin-converting enzymeinhibitors and angiotensin iireceptor blockers synergistically increasecoronary blood flow in canine ischemic myocardium: Role of bradykinin

687

Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training

688

Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial

689

Angiotensin-converting-enzyme inhibitors in early pregnancy

690

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

691

Angiotensin-I converting enzyme inhibitory peptides from antihypertensive skate (Okamejei kenojei) skin gelatin hydrolysate in spontaneously hypertensive rats

692

Angiotensin-I-converting enzyme (ACE)-inhibitory and antihypertensive properties of squid skin gelatin hydrolysates

693

Angiotensin-I-converting enzyme and prolyl endopeptidase inhibitory peptides from natural sources with a focus on marine processing by-products

694

Angiotensin-I-converting enzyme inhibitory activity and bitterness of enzymatically-produced hydrolysates of shrimp (Pandalopsis dispar) processing byproducts investigated by Taguchi design

695

Angiotensin-II activates apoptosis, proliferation and protein synthesis in the left heart ventricle of newborn albino rats

696

Angiotensin-II receptor antagonist losartan improves the exercise tolerance in patients with symptomatic congestive heart failure

697

Angiotensin-II type 1 receptor polymorphism is associated with an increased vasoreactivity to angiotensin II in human arteries

698

Angiotensin-II-receptor inhibitors in pregnancy

699

Angiotensin-II-receptor inhibitors in pregnancy

700

Angiotensin-II-receptor inhibitors in pregnancy

701

Angiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: The atherosclerosis risk in communities and the NHLBI family heart studies Original Research Article

702

Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia

703

Angiotensinogen expression by rat epididymis: evidence for an intrinsic, angiotensin-generating system

704

Angiotensinogen Gene M235T and T174M Polymorphisms in Diabetic Nephropathy in a Bangladeshi Population

705

Angiotensinogen Gene M235T and T174M Polymorphisms in Essential Hypertension: Relation With Target Organ Damage

706

Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes

707

Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy

708

Angiotensinogen gene polymorphism is associated with insulin resistance in nondiabetic men with or without coronary heart disease, , ,

709

Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial

710

Angiotensinogen genotype affects HDL levels in afro-caribbeans

711

Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease, ,

712

Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients

713

Angiotensinogen Promoter Sequence Variants in Essential Hypertension

714

Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis

715

Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua, ,

716

Angiotensins differentially activate phospholipase d in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats

717

Angiotension AT1Receptor Inhibition in Pacing Induced Heart Failure: Effects on Left Ventricular Myocardial Collagen Content and Composition

718

Angiotension-converting enzyme gene I/D polymorphism in patients with angina and normal coronary arteriograms

719

Angiotropic large B-cell lymphoma with clinical features resembling subacute combined degeneration of the cord

720

AngioVac System Used for Vegetation Debulking in a Patient with Tricuspid Valve Endocarditis: A Case Report and Review of the Literature

721

Angle amplification for nanoradian measurements

722

Angle and aspect dependent dew and fog precipitation in the Negev desert

723

Angle and Context Free Grammar Based Precarious Node Detection and Secure Data Transmission in MANETs

724

Angle- and gender-specific quadriceps femoris muscle recruitment and knee extensor torque

725

Angle and thickness dependence of magnetoresistance peaks in thin nickel films

726

ANGLE AND TIME OF ARRIVAL STATISTICS OF A THREE DIMENSIONAL GEOMETRICAL SCATTERING CHANNEL MODEL FOR INDOOR AND OUTDOOR PROPAGATION ENVIRONMENTS

727

ANGLE AND Z BEAMS IN BENDING: TENSOR MATRIX METHOD FOR SPREADSHEETS

728

ANGLE AND Z BEAMS IN BENDING: TENSOR MATRIX METHOD FOR SPREADSHEETS

729

Angle counts for isothetic polygons and polyhedra

730

Angle criteria for frame sequences and frames containing a Riesz basis

731

Angle decomposition of matrices Original Research Article

732

Angle dependence of intravascular ultrasound imaging and its feasibility in tissue characterization of human atherosclerotic tissue

733

Angle Dependence of Magnetic Oscillations in (TMTSF)2FSO3

734

Angle dependent condensing efficiency of Winston cone in terahertz region

735

Angle dependent laser nanopatterning of poly(ethylene terephthalate) surfaces

736

Angle dependent magnetoresistance oscillation study of the fermi surface of β″-(BEDT-TTF)2AuBr2

737

Angle dependent magnetoresistance oscillations of α-(BEDT-TTF)2KHg(SCN)4 under high pressure

738

Angle dependent magnetoresistance oscillations of β-(BEDT-TTP)2I3

739

Angle dependent X-ray photoemission study on UV-ozone treatments of indium tin oxide

740

Angle design of stator-rotor blades for VLH axial flow turbine using surrogate-based optimization

741

Angle distortion and conformality

742

Angle diversity and rate-adaptive transmission for indoor wireless optical communications

743

Angle estimation for two unresolved targets with monopulse radar

744

Angle Formed Between Patent Ductus Arteriosus and Descending Thoracic Aorta in a Beating Heart: A Helpful Study to Design a Better Device for Occluding Patent Ductus Arteriosus

745

Angle Kappa Measurements: Normal Values in Healthy Iranian Population Obtained With the Orbscan II

746

Angle of arrival estimation using spectral interferometry

747

Angle of Attack Investigations on the Performance of a Diverterless Supersonic Inlet

748

Angle of contact between sheet and die during stretch–bend deformation as determined on the bending-under-tension friction test system

749

Angle of incidence effects in a molecular solid

750

Angle of repose of landslide debris deposits induced by 2008 Sichuan Earthquake

751

Angle Optimization Algorithms For Five-Axis Milling Machines

752

Angle paradigm: A new method to measure right parietal dysfunctions in anorexia nervosa

753

754

Angle resolved imaging of polymer blend systems: From images to a 3D volume of material morphology

755

Angle Resolved Photoemission Spectroscopy of the InP 001/ surface

756

Angle resolved photoemission studies on Sm2−xCexCuO4: remnant Fermi surfaces and coupling to (π,π) scattering Original Research Article

757

Angle resolved photoemission study of image potential states and surface states on Cu(1 1 1)

758

Angle resolved photoemission study of quasi one-dimensional SrCuO2 by soft X-ray excitation

759

Angle resolved photoemission study of the Ce/Pd(1 1 1) interface

760

Angle resolved photoemission study of the spin-Peierls system α′-NaV2O5

761

Angle resolved ultraviolet photoelectron spectroscopy of oriented sexiphenyl layers

762

Angle resolved XPS of monomolecular layer of 5-chlorobenzotriazole on oxidized metallic surface

763

Angle resolved XPS studies on an anodic oxide formed on Ti–Nb–Sn alloy and the photo-induced change in carbon contaminants adsorbed on its surface

764

Angle resolved XPS study of inhomogeneous specimens of polycrystalline silver covered with uniform graphite overlayers

765

Angle resolved X-ray photoelectron spectroscopy study of Au deposited on Pt and Re surfaces

766

Angle resolved X-ray photoelectron spectroscopy study of Pd/NbOx/Nb interfaces

767

Angle strain and conjugation in conformations of heptafulvenes

768

ANGLE v2.1—New version of the computer code for semiconductor detector gamma-efficiency calculations

769

ANGLE v2.1—New version of the computer code for semiconductor detector gamma-efficiency calculations

770

Angle, energy and mass-resolved ion spectroscopy of core-excited polyatomic molecules

771

Angle, energy and mass-resolved ion spectroscopy of core-excited polyatomic molecules

772

Angle-, field-, temperature-, and size-dependent magnetic circular X-ray dichroism in Au/Co nanoclusters/Au(1 1 1)

773

ANGLE: An autonomous, normative and guidable agent with changing knowledge

774

Angle-adjustable sheath for a dual-stage venous cannula

775

Angle-Analyzer: A Triangle-Quad Mesh Codec

776

Angle-averaged effective proton–carbon analyzing powers at intermediate energies

777

Angle-averaged effective proton–carbon analyzing powers at intermediate energies

778

Angle-correlated spectrum measurement for two neutrons emitted from (n, 2n) reaction with the coincidence detection technique using a pencil-beam DT neutron source

779

Angle-correlated spectrum measurement for two neutrons emitted from (n, 2n) reaction with the coincidence detection technique using a pencil-beam DT neutron source

780

Angled abutments result in increased or decreased stress on surrounding bone of single-unit dental implants: A finite element analysis

781

Angle-dependence of the magnetotransport and Anderson localization in a pressure-induced organic superconductor

782

Angle-dependent cyclotron resonance in organic Q2D conductors

783

Angle-dependent infrared absorption spectroscopy at electrode/electrolyte interfaces

784

Angle-dependent light scattering in materials with controlled diffuse solar optical properties

785

Angle-dependent magnetoresistance oscillations and Fermi surface reordering at high magnetic fields in α-(ET)2KHg(SCN)4

786

Angle-dependent magneto-transport measurements on κ- (BEDT-TTF)2Cu(NCS)2 under pressure

787

Angle-dependent Mِssbauer study of the ground and second new metastable state in Na2[Fe(CN)5NO]·2H2O single crystals

788

Angle-dependent polariton collisional broadening in semiconductor microcavities

789

Angle-dependent switching of granular and multilayer perpendicular media

790

Angle-dependent ultraviolet photoelectron spectroscopy of sputter cleaned polycrystalline noble metals

791

Angle-dependent XPS analysis of silicon nitride film deposited on screen-printed crystalline silicon solar cell

792

Angle-dependent XPS study of functional group orientation for aminosilicone polymers adsorbed onto cellulose surfaces

793

Angle-dependent XPS study of the mechanisms of ‘‘high–low temperature’’ activation of GaAs photocathode

794

ANGLE-DIFFERENTIAL CROSS SECTIONS FOR RADIATIVE RECOMBINATION AND THE PHOTOELECTRIC EFFECT IN THE K, L, AND M SHELLS OF ONE-ELECTRON SYSTEMS CALCULATED WITHIN AN EXACT RELATIVISTIC DESCRIPTION

795

Angle-dispersive diffraction with synchrotron radiation at Laboratório Nacional de Luz Síncrotron (Brazil): potential for use in biomedical imaging

796

Angle-monotonicity of theta-graphs for points in convex position

797

Angle-resolved analysis of desorbed species in pulsed laser ablation on cadmium tungstate single crystal surfaces with different orientations studied by time-of-flight mass spectrometry

798

Angle-resolved and resonant photoemission study of the ZrO-like film on ZrC(1 0 0)

799

Angle-resolved characteristics of silicon photovoltaics with passivated conical-frustum nanostructures

800

Angle-resolved elastic peak electron spectroscopy: Role of surface excitations

801

Angle-resolved elastic-peak electron spectroscopy: Solid-state effects

802

Angle-resolved electron and ion spectroscopy apparatus on the soft X-ray photochemistry beamline BL27SU at SPring-8

803

Angle-resolved electron and ion spectroscopy apparatus on the soft X-ray photochemistry beamline BL27SU at SPring-8

804

Angle-resolved electron-electron and electron-ion coincidence spectroscopy: new tools for photoionization studies

805

Angle-resolved electron–electron and electron–ion coincidence spectroscopy: new tools for photoionization studies

806

Angle-resolved electronic decay of the π*, σ* and Rydberg resonances below the O K-edge in O2

807

Angle-resolved inverse photoemission of H-etched 6H-SiC (0001)

808

Angle-resolved inverse photoemission of the (2×1)-reconstructed 3C-SiC(0 0 1) surface

809

Angle-resolved inverse photoemission of the (2×1)-reconstructed 3C-SiC(0 0 1) surface

810

Angle-resolved ion yield spectroscopy for the 1s → 3π excited states in hot N2O molecules

811

Angle-resolved ion–electron coincidence experiments in molecular photoionization

812

Angle-resolved low-energy ion scattering studies of quasicrystalline Al–Pd–Mn

813

Angle-resolved measurements of product desorption and reaction dynamics on individual sites

814

Angle-resolved photoelectron spectroscopy of the satellite bands accompanying the O 1s mainline of CO2

815

Angle-resolved photoemission electron spectroscopy reveals a Fermi surface remnant with a d-wave like dispersion in the Mott insulator, Ca2CuO2Cl2

816

Angle-resolved photoemission from atomic-layer-resolved quantum well states in Ag/Fe(100)

817

Angle-resolved photoemission from stoichiometric GaN(0 0 0 1)-1 × 1

818

Angle-resolved photoemission measurements of omega-(n-pyrrolyl)alkanethiol self-assembled monolayers using in-situ sample preparation apparatus

819

Angle-resolved photoemission measurements of ω-(n-pyrrolyl)alkanethiol self-assembled monolayers using in-situ sample preparation apparatus

820

Angle-resolved photoemission spectroscopy measurements on (1 × 1) and (5 × 1) Pt(1 0 0)

821

Angle-resolved photoemission spectroscopy of band tails and anomalous kinetics of underdoped cuprates Original Research Article

822

Angle-resolved photoemission spectroscopy of SrCuO2: spin-charge separation?

823

Angle-resolved photoemission spectroscopy study of Fe(1 1 0) single crystal: Many-body interactions between quasi-particles at the Fermi level

824

Angle-resolved photoemission studies of the cuprate superconductors

825

Angle-resolved photoemission study for double Ag nano®lm structures

826

Angle-resolved photoemission study of Ag nanofilms grown on fcc transition-metal (111) substrates

827

Angle-resolved photoemission study of Co nanostructures on vicinal Au(1 1 1) surfaces

828

Angle-resolved photoemission study of CoSi2 nanofilms grown on Si(111) substrates

829

Angle-resolved photoemission study of Cu on ZnO(1 0 0); room temperature deposition and annealing effect

830

Angle-resolved photoemission study of Fe on a vicinal Au (7 8 8) surface

831

Angle-resolved photoemission study of quantized electronic structures on Ag nanofilms

832

Angle-resolved photoemission study of quasi one-dimensional conductor Nb3Te4

833

Angle-resolved photoemission study of the hydrogenated 3C-SiC(0 0 1)-2×1-H surface

834

Angle-resolved photoemission study of the surface electronic structure on NdB6 (110) clean surface

835

Angle-resolved photoemission study on the superconducting iron-pnictides of BaFe2(As,P)2 with low energy photons

836

Angle-resolved photofragmentation of the N K-shell excited CF3CN molecule

837

Angle-resolved spectator decay of vibrationally selected C 1s(2σ)−12π1 excited states in carbon monoxide

838

Angle-resolved study of hydrogen abstraction on Si(1 0 0) and Si(1 1 1): Evidence for non-activated pathways

839

Angle-resolved tunneling study on the anisotropic gap of Bi-2212 superconducting whisker

840

Angle-resolved ultraviolet photoelectron microspectroscopy

841

Angle-resolved ultraviolet photoelectron spectroscopy study on the α-Si(1 1 1)3×3-Bi surface

842

Angle-resolved UPS study and simulation with IAC approximation for oriented monolayer of tetratetracontane (n-C44H90) on Cu(100)

843

Angle-resolved XPS depth-profiling strategies

844

Angle-resolved XPS measurements on copper phthalocyanine thin films

845

Angle-resolved XPS studies on transition layers at SiO2/Si interfaces

846

Angle-resolved X-ray photoelectron spectroscopic study of the interface chemistry between ultra-thin aC overcoat and the magnetic layer on magnetic thin film disks

847

Angle-resolved X-ray photoelectron spectroscopic study of the interface chemistry between ultra-thin a-C overcoat and the magnetic layer on magnetic thin film disks

848

Angle-resolved X-ray photoelectron spectroscopy of topmost surface for LaNiO thin film grown on SrTiO substrate by laser 3 3 molecular beam epitaxy

849

Angle-resolved X-ray photoelectron spectroscopy study of the oxides on Nb surfaces for superconducting r.f. cavity applications

850

Angle-resolved-photoemission study of layer-structured nitride β-HfNCl

851

Anglersʹ perceptions of recreational fisheries and fisheries management in Mallorca

852

Angles between infinite dimensional subspaces with applications to the Rayleigh–Ritz and alternating projectors methods

853

Angles in Laguerre tessellation models for solid foams

854

Angle-scanned photoemission spectrum from Cu(1 0 0): theory vs experiment

855

Angle-scanned photoemission spectrum from Cu(1 0 0): theory vs experiment

856

Anglesite (PbSO4) leaching in citrate solutions

857

Anglesite flotation: a study for lead recovery from zinc leach residue

858

Angle-specific impairment of elbow flexors strength after isometric exercise at long muscle length

859

Angle-stable top-emitting white organic light-emitting devices employing a down-conversion layer

860

Angle-upported phakic intraocular lene followed by laer-aited in itu keratomileui for the correction of high myopia

861

Angle-velocity-resolved measurements of I(2P3/2,1/2) from (CH3I)n cluster photodissociation at 266 and 304 nm

862

Anglicism in the Translated Version of Headlines in Malay Printed Catalogues

863

Angling and recreation values of low-flow alleviation in rivers

864

Angling management organizations: integrating the recreational sector into fishery management

865

Anglo-American nursing theory, individualism and mental health care: a social conflict perspective

866

Anglo-American town planning theory since 1945: three significant developments but no paradigm shifts

867

Anglo-Saxon and German approaches to neoliberalism and environmental policy: The case of financing renewable energy

868

Anglo-Saxon and German life-cycle costing

869

Anglo-Saxon animal husbandry techniques revealed though isotope and chemical variations in cattle teeth

870

Anglo-Saxon Axis in 2003:Blairʹʹs Doctrine and Bush Invasion of Iraq

871

Angolan Cymbopogon citratus used for therapeutic benefits: Nutritional composition and influence of solvents in phytochemicals content and antioxidant activity of leaf extracts

872

Angolaʹs suffering behind a pretence of normality

873

Angor in a child: Left main coronary artery atresia

874

ANGPTL4 suppresses the profibrogenic functions of atrial fibroblasts induced by angiotensin II by up-regulating PPARγ

875

Angry and Aggressive Behavior Across Three Generations: A Prospective, Longitudinal Study of Parents and Children

876

Angry and Aggressive Behavior Across Three Generations: A Prospective, Longitudinal Study of Parents and Children

877

Angry Bird s Revenge: Hepatic Abscesses Secondary to Colonic Perforation

878

Angry memories and thoughts of revenge: The relationship between forgiveness and anger rumination

879

Angry men and disgusted women: An evolutionary approach to the influence of emotions on risk taking

880

Angry parents: a group psychotherapy manual for aggression management training

881

Angry? Letʹs talk about it!

882

ANGST OVER UNIVERSITY RANKINGS

883

Angstrom turbidity and ozone column estimations from spectral solar irradiance in a semi-desertic environment in Spain

884

Angstrom-beam electron diffraction of amorphous materials

885

Angstrom-Range Optical Path-Length Measurement with a High-Speed Scanning Heterodyne Optical Interferometer

886

Anguilla anguilla L. Biochemical and Genotoxic Responses to Benzo[a]pyrene

887

Anguilla anguilla L. genotoxic and liver biotransformation responses to abietic acid exposure

888

Anguilla anguilla L. liver EROD induction and genotoxic responses after retene exposure

889

Anguilla anguilla L. liver ethoxyresorufin O-deethylation, glutathione S-tranferase, erythrocytic nuclear abnormalities, and endocrine responses to naphthalene and β-naphthoflavone

890

Anguilla anguilla L. oxidative stress biomarkers responses to copper exposure with or without β-naphthoflavone pre-exposure

891

Anguilla anguilla L. oxidative stress biomarkers: An in situ study of freshwater wetland ecosystem (Pateira de Fermentelos, Portugal)

892

Anguilla anguillaL. Stress Biomarkers Recovery in Clean Water and Secondary-Treated Pulp Mill Effluent

893

Anguish over angiopathy: Hemolytic uremic syndrome

894

Anguishing Reports of Ambient Air Pollution in Tehran Capital of Iran

895

Angular (cis-stilbazole) geometry in octahedral dimethyldihalidoplatinum(IV) complexes: potential as metallomesogens and X-ray structure of [PtMe2I2(NC5H4CHCHC6H4OC7H15)2]

896

Angular analysis of bremsstrahlung in α-decay

897

Angular analysis of the muon pair asymmetry at LEP 1

898

Angular and energy analysis of HeH+ products from the charge exchange excitation reaction

899

Angular and energy dependences of the surface excitation parameter for electrons crossing a solid surface

900

Angular and energy dependences of the surface excitation parameter for semiconducting III–V compounds

901

Angular and fibrous particles in lung are markers of job categories

902

Angular and hyperangular momentum recoupling, harmonic superposition and Racah polynomials: a recursive algorithm

903

Angular and polarization dependence of Compton scattering from 4He in the Δ-resonance region

904

Angular and polarization effects in relativistic potential scattering of electrons in a powerful laser field

905

Angular and power characteristics of noncollinear acousto-optic tunable filters

906

Angular and radial geometries, charge transfer and binding strength in isolated complexes B⋯ICl: some generalisations

907

Angular and time resolution of neutron time of flight spectrometers

908

Angular and unrestricted limits of one-parameter semigroups in the unit disk

909

Angular and velocity distributions of desorbing molecules in steady-state NO+CO reaction on Pd(110)

910

Angular and velocity distributions of small cluster fragments in neutral (NH3)n scattering off LiF(100) Original Research Article

911

Angular anisotropy of products in the photodissociation of propene at 157 nm

912

Angular characterization of low concentrating PV–CPC using low-cost reflectors

913

Angular collection using solenoids

914

Angular collection using solenoids

915

Angular confinement and concentration in photovoltaic converters

916

Angular correlation of photons emitted from an excited quantum well

917

Angular correlation of ultra-high energy cosmic rays with compact radio-loud quasars

918

Angular correlations and statistical entropy of hard spherocylinders: the isotropic–nematic transition

919

Angular correlations in double ionization of Helium by high-energy Compton scattering

920

Angular correlations in double ionization of Helium by high-energy Compton scattering

921

Angular correlations of high momentum photons at 158 A GeV p+A and Pb+Pb collisions Original Research Article

922

Angular Deformities of the Lower Limb in Children

923

Angular dependence from L3-subshell to M-shell vacancy transfer probabilities for heavy elements using EDXRF technique

924

Angular dependence in photoemission: from atoms to surfaces to atoms

925

Angular dependence of dissociation in steering dominated activated reaction

926

Angular dependence of energy and particle fluxes in a magnetized plasma

927

Angular dependence of forward scattering induced by condensate on greenhouse cladding materials

928

Angular dependence of magnetic reversal in two-phased nanolayers

929

Angular dependence of magnetization reversal process in patterned Co thin films

930

Angular dependence of magnetoresistance in SDW state of (TMTSF)2PF6

931

Angular dependence of magnetoresistance of several Bechgaard salts

932

Angular dependence of particle correlations in pp collisions at 400 GeV/c

933

Angular dependence of particle correlations in π+K+p eractions at 250 GeV/c

934

Angular dependence of quartz fiber calorimeter response

935

Angular Dependence of Rayleigh-Wave Velocity in Prestressed Polycrystalline Media with Monoclinic Texture

936

Angular dependence of shot noise in the presence of Rashba spin–orbit coupling in semiconductor spintronics junctions

937

Angular dependence of the floating potential in a magnetized plasma

938

Angular dependence of the high field phase transition in α-(BEDT-TTF)2TlHg(SCN)4

939

Angular dependence of the magnetic-field driven superconductor–insulator transition in thin films of amorphous indium-oxide

940

Angular dependence of the magnetoresistance of TiSi2 single crystals

941

Angular dependence of the sputtering yield of water ice by 100 keV proton bombardment

942

Angular dependence of the two-electron intex distribution

943

Angular dependence of the unusual first-order transition temperature in single-crystal Gd/sub 5/(Si/sub ~0.5/Ge/sub ~0.5/)/sub 4/

944

Angular dependence of the wall correction factor for air kerma measurements using cylindrical cavity chambers

945

Angular dependence of vicinal carbon-proton coupling constants for conformational studies of the hydroxymethyl group in carbohydrates

946

Angular dependence of vortex matter phase transition in MgB2 single crystal Original Research Article

947

ANGULAR DEPENDENCE OF WAVE REFLECTION IN A LOSSY SINGLE-NEGATIVE BILAYER

948

Angular dependences in electroweak semi-inclusive leptoproduction Original Research Article

949

Angular dependences in inclusive two-hadron production at BELLE Original Research Article

950

Angular dependences of the switching field and coercivity for magnetic multilayer films with strain caused by lattice mismatch

951

Angular dependencies of exchange bias and coercivity in the ferromagnetic/antiferromagnetic bilayers not subjected to field-cooling treatments

952

Angular dependent magnetization studies of α-(BEDT-TTF)2KHg(SCN)4

953

Angular dependent magnetotransport and electronic structure in quasi-one-dimensional organic conductor (TMTSF)2ClO4

954

Angular dependent measurements of the ν=52 fractional quantum Hall effect state at ultra-low temperatures

955

Angular Derivatives of Holomorphic Maps in Infinite Dimensions

956

Angular dimensions of planetary nebulae

957

Angular dispersion of polar phonons in a hexagonal GaN–AlN superlattice

958

Angular displacement-enhanced heterodyne polarimeter for the measurement of optically active media

959

Angular distortion and through-thickness residual stress distribution in the friction-stir processed 6061-T6 aluminum alloy

960

Angular distribution and direct CP violation with perturbative strong phases in B → W decays

961

Angular distribution and polarization of photons in the inclusive decay Λb → Xsγ

962

Angular distribution anisotropy of fragments ejected from methyl iodide clusters: Dependence on fs laser intensity

963

ANGULAR DISTRIBUTION COEFFICIENTS FOR γ-RAY POLARIZATIONS PRODUCED IN POLARIZED CAPTURE REACTIONS

964

Angular distribution for the electron recoil in pair production by linearly polarized - rays on electrons

965

Angular distribution for the electron recoil in pair production by linearly polarized - rays on electrons

966

Angular distribution of Bremsstrahlung photons and of positrons for calculations of terrestrial gamma-ray flashes and positron beams

967

Angular distribution of Cherenkov light from electrons both produced and stopping in water

968

Angular distribution of Cherenkov light from electrons both produced and stopping in water

969

Angular distribution of coherent bremsstrahlung

970

Angular distribution of coherent bremsstrahlung

971

Angular distribution of decay leptons from e+e−→W+W− at threshold

972

Angular distribution of desorbing/permeating deuterium from modified Pd(1 1 1) surfaces

973

Angular distribution of Drell–Yan process at hadron colliders to NLO-QCD in models of TeV scale gravity Original Research Article

974

Angular distribution of ejected electrons from Ba 6pns (J=1) autoionizing states

975

Angular distribution of electrons elastically backscattered from amorphous overlayer systems

976

Angular Distribution of Gamma-Ray Bursts and Weak Lensing

977

Angular distribution of highly charged ions transmitted through metallic microcapillaries

978

Angular distribution of intensity of reflected radiation investigations of the influence of CO2 laser treatment on optical properties of hydrogenated amorphous silicon

979

Angular distribution of leptons in general tt̄ production and decay

980

Angular Distribution of Light Scattered by Single Biological Cells and Oriented Particle Agglomerates

981

Angular distribution of neutrons from heavy ion induced reactions in thick targets

982

Angular distribution of neutrons from heavy ion induced reactions in thick targets

983

Angular distribution of nonlinear harmonic generation in helical undulators: A comparison between experiments and theory

984

Angular distribution of nonlinear harmonic generation in helical undulators: A comparison between experiments and theory

985

Angular distribution of oxide films deposited by multi- or single-component laser ablation

986

Angular distribution of particles sputtered from GaAs by Ar+ and Xe+ ion bombardment

987

Angular distribution of photoelectrons emitted from solids

988

Angular distribution of photoelectrons from nickel: test of modified common XPS formalism

989

Angular distribution of photoelectrons from solids with account for elastic scattering and non-dipolar transitions up to the second order corrections: the linearly polarized excitation

990

Angular distribution of radiation beneath forest canopies using a CCD-radiometer

991

Angular distribution of scattered electrons associated with collimated bremsstrahlung and the tagging technique

992

Angular distribution of scattered electrons associated with collimated bremsstrahlung and the tagging technique

993

Angular distribution of scattered radiation under broken cloud arrays: An approximation of successive orders of scattering

994

Angular distribution of species in pulsed energy beam deposition of oxide films

995

Angular distribution of sputtered matter under Cs+ bombardment with oblique incidence

996

Angular distribution of surface excitations for electrons backscattered from Al and Si surfaces

997

Angular distribution of the photoelectrons from solids with account for elastic scattering and non-dipolar transitions

998

Angular distribution of the photoelectrons from solids with account for elastic scattering and non-dipolar transitions: the linearly polarized excitation

999

Angular distribution of transient radiation from an ultrarelativistic particle in a magnetic field

1000

Angular distribution of X-ray photoelectrons emitted from silver

بازگشت